Did we miss something that will have a major impact on pharma marketing this year? We asked our respondents to write their own questions and answer them.
Life sciences and pharmaceutical brands understand that increased commercial performance and growth are only possible through optimized customer engagement and satisfaction.
Insights from CMI Media Group’s Media Vitals Research, specially prepared for MedAdNews
As we settle ourselves into 2023, this transition continues. Pharma marketers should prepare for a period of recalibration, transparency, and connection.
As pharma marketers, we strive to be patient-centric. We create and analyze patient journeys, conduct in-depth research, and even co-create materials, all with the focus of creating personalized, engaging campaigns that empower and educate patients. Sometimes, though, the science takes a leap of such breadth and scale that it changes the very concept and meaning of patient-centricity.
AI technologies have the capacity to revolutionize the practice of medicine – if human HCPs can learn to trust them first.
Med Ad News and industry reflect on the life and legacy of Sander Flaum, a pharma sales and marketing expert, motivational coach, accomplished author, and industry friend.
A review of the latest executive moves in the pharma industry.
The combined capabilities will help improve trial lifecycles for patients, sites, and sponsors.
One Health is the concept that the health of humans, animals, and the environment are inextricably linked. Therefore, medical and veterinary professionals as well as those in other scientific, health, and environmental disciplines should communicate and collaborate, instead of working in isolation.